Disease characteristics and outcomes in patients with chronic kidney disease and type 2 diabetes: a matched cohort study of spironolactone users and non-users

BACKGROUND: Limited evidence has indicated that addition of a steroidal mineralocorticoid receptor antagonist (MRA) to the standard of care reduces proteinuria in patients with diabetic kidney disease (DKD); however, there are limited data regarding real-world MRA use in these patients. This study a...

Descripción completa

Detalles Bibliográficos
Autores principales: Blankenburg, Michael, Kovesdy, Csaba P., Fett, Anne-Kathrin, Griner, Raymond G., Gay, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045439/
https://www.ncbi.nlm.nih.gov/pubmed/32101152
http://dx.doi.org/10.1186/s12882-020-01719-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045439/
https://www.ncbi.nlm.nih.gov/pubmed/32101152
http://dx.doi.org/10.1186/s12882-020-01719-7

Ejemplares similares